MTBC Extends Exclusive Offer to McKesson Software Users Facing Switch to E-MDs
SOMERSET, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced that it is offering users of McKessonTM software, reportedly being sold to E-MDsTM, an exclusive offer to transition to MTBC.
“MTBC’s platform is a robust, intuitive, certified EHR solution, which significantly outranked McKesson software in a KlasTM survey of one-to-ten provider groups,” said Loraine Goetsch, a member of MTBC’s leadership team who spearheads strategic sales and marketing initiatives. She added, “Our exclusive offer for McKesson users is specifically tailored to assist them in transitioning smoothly, without worrying about data conversion fees, cost of training and support, and a decline in their revenue.”
As providers throughout the industry are gravitating toward fully-integrated solutions like MTBC’s PracticeProTM, key industry players, from Practice FusionTM to McKesson, are reportedly choosing to sell or sunset their proprietary software solutions. On a parallel track, MTBC will continue to enhance its fully-integrated, industry-leading suite of solutions, attaining regulatory certifications, creating highly ranked mobile apps, and more.
MTBC is offering users of McKesson software products, including Lytec, Medisoft, Practice Partner and Practice Choice, the following:
- Free data conversion to the MTBC EHR platform
- Free training and support
- Free license to use the MTBC EHR for 3 years (with no additional commitment required)
- Ability to leverage MTBC’s broader integrated practice management platform and services at standard rates
“For many years, we have been helping providers throughout the country improve clinical and business workflows, while reducing expenses and increasing revenues,” said Stephen Snyder, MTBC President. He added, “We look forward to delivering these same results to users who take advantage of this unique promotional offer.”
To learn more about MTBC, please visit www.mtbc.com or call (866) 266-6822.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Forward-Looking Statements.
This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "goals", "intend", "likely", "may", "plan", "potential", "predict", "project", "will" or the negative of these terms or other similar terms and phrases.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors are including, but not limited to the Company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Klas is a registered trademark of Klas Enterprises LLC and did not authorize or participate in this release. MTBC participated in the 2014 Best in Klas Survey which ranks healthcare vendors and solutions through feedback from their users.
McKesson, including Lytec, Medisoft, Practice Partner and Practice Choice, are registered trademarks of McKesson Corporation and did not authorize or participate in this release. E-MDs is a registered trademark of e-MDs Inc and did not authorize or participate in this release. Practice Fusion is a registered trademark of Practice Fusion, Inc. and did not authorize or participate in this release.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC adeol@mtbc.com (732) 873-5133 x 141
Released March 17, 2016